Dr. Ratner is a Board Certified Gynecologic oncologist with special interests in chemotherapy targeted drug development, patient quality of life programs and early cancer detection. She is the current co-director of Discovery To Cure, director of Discovery to Cure Early Ovarian Cancer Detection program and a founder and director of Sexuality, Intimacy and Menopause cancer survivorship program. Dr. Ratner's laboratory is working on new targeted drugs for ovarian cancer in order to provide patients with truly personalized care. Her work additionally focuses on reversing chemotherapy resistance in ovarian and uterine cancers. Dr. Ratner is a recipient of multiple clinical and teaching awards, most recently 2015 Yale University Smilow Cancer Center Award for Clinical Excellence. Education & Training